Search Log In

fig3

From:  Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?
Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?

Figure 3. Examples of non-standard 20S proteasomes containing β5i-β1i-β2 or β5i-β1-β2 composition.

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
partners@oaepublish.com Company Contact Us
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2024 OAE Publishing Inc., except certain content provided by third parties